A Scientist’s Guide to Immunogenicity Testing in Biologics
- No Comments
In the development of biologic drugs—from monoclonal antibodies to gene therapies—few challenges are as critical and complex as understanding immunogenicity. The potential for a therapeutic to elicit an unwanted immune response in patients can profoundly impact its safety and efficacy. For drug developers, a robust immunogenicity testing strategy is not just a regulatory requirement; it’s […]
Read More